Wowtab

Yamanouchi Shaklee Pharma and J&J/Merck form an agreement for the development of an OTC product using Yamanouchi's Wowtab technology for quick-dissolving tablets that can be taken without water. J&J/Merck Consumer markets Mylanta and Pepcid AC antacids and stomach acid blockers. No OTCs using the Wowtab system are on the market; the J&J/Merck deal is the first such arrangement to be disclosed. Yamanouchi signed an agreement with Glaxo Wellcome recently for an Rx migraine therapy using the technology. Wowtab tablets are hard and stable, allowing bottle or blister packaging, but melt in the mouth in 15 seconds or less without water, the firm says...